ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Interim, IR, Listing Regulation, News, Regulatory, Report, Swedish, Yearend
November 18, 2024
17 Feb 2022

Acarix AB (publ) publicerar Bokslutskommuniké 2021

Pressmeddelande Malmö, 17 februari 2022   Acarix AB (publ) publicerar Bokslutskommuniké 2021 Grunden ä...
Continue reading
author-avatar acarix
English, Interim, IR, Listing Regulation, News, Regulatory, Report, Yearend
November 18, 2024
17 Feb 2022

Acarix AB (publ) publishes Year-End Report 2021

Press release Malmö, Sweden, February 17, 2022   Acarix AB (publ) publishes Year-End Report 2021 Groundwork laid ...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
09 Feb 2022

Acarix lämnar in ansökan om status som Breakthrough Therapy till FDA vid diagnosen hjärtsvikt

Pressmeddelande Malmö, 9 februari 2022   Acarix lämnar in ansökan om status som Breakthrough Therapy til...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
09 Feb 2022

Acarix submits breakthrough designation request with FDA for heart failure diagnosis

Press release Malmö, Sweden, February 9, 2022   Acarix submits breakthrough designation request with FDA for heart...
Continue reading
author-avatar acarix
Corporate Information, Financial calendar, IR, Listing Regulation, News, Regulatory, Swedish
November 18, 2024
09 Feb 2022

Acarix AB (publ) tidigarelägger publicering av delårsrapport för fjärde kvartalet till den 17 februari 2022

PressmeddelandeMalmö, 9 februari, 2022 Acarix AB (publ) tidigarelägger publicering av delårsrapport för fjär...
Continue reading
author-avatar acarix
Corporate Information, English, Financial calendar, IR, Listing Regulation, News, Regulatory
November 18, 2024
09 Feb 2022

Acarix AB (publ) brings forward publication of interim report for fourth quarter to February 17, 2022

Press release Malmö, Sweden, February 9, 2022   Acarix AB (publ) brings forward publication of interim report for ...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
07 Feb 2022

Acarix invites to virtual Capital Market Day

Press releaseMalmö, Sweden, February 7, 2022 Acarix invites to virtual Capital Market Day Acarix is stepping up commercializa...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
07 Feb 2022

Acarix bjuder in till virtuell kapitalmarknadsdag

Press release Malmö, 7 februari, 2022 Acarix bjuder in till virtuell kapitalmarknadsdag Acarix, noterat på Nasdaq First ...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Regulatory, Staff change
November 18, 2024
10 Jan 2022

Acarix appoints US based Helen Ljungdahl Round as new CEO

Press release (MAR)Malmö, Sweden, January 10, 2022 Acarix appoints US based Helen Ljungdahl Round as new CEO The Board of Acarix...
Continue reading
author-avatar acarix
Corporate Information, IR, MAR, News, Regulatory, Staff change, Swedish
November 18, 2024
10 Jan 2022

Acarix utser USA-baserade Helen Ljungdahl Round till ny VD

Press release (MAR)Malmö, 10 januari, 2022 Acarix utser USA-baserade Helen Ljungdahl Round till ny VD Styrelsen för Acarix ...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
29 Dec 2021

Acarix carries out a directed issue of shares to guarantors in conjunction with completed rights issue

Press release Malmö, December 29, 2021 Acarix carries out a directed issue of shares to guarantors in conjunction with completed ...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, Listing Regulation, News, Regulatory, Shares, Swedish
November 18, 2024
29 Dec 2021

Acarix genomför riktad nyemission av aktier till garanter i samband med avslutad företrädesemission

Press release Malmö, 29 december, 2021 Acarix genomför riktad nyemission av aktier till garanter i samband med avslutad f&o...
Continue reading
  • «
  • ‹
  • 19
  • 20
  • 21
  • 22
  • 23
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.